Connect with us

Technology

Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results

Published

on

Highlights

Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currencyInstruments returned to growth; recurring revenue grew high single-digits in constant currencyAll reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & IndustrialGAAP EPS of $2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by strong operational performance and better-than-expected market conditionsRaised full-year sales and EPS guidance, with 5% to 7% constant currency growth expected in the fourth quarter

Third Quarter 2024

MILFORD, Mass., Nov. 1, 2024 /PRNewswire/ — Waters Corporation (NYSE: WAT) today announced its financial results for the third quarter of 2024.

Sales for the third quarter of 2024 were $740 million, an increase of 4% as reported, compared to sales of $712 million for the third quarter of 2023. Currency translation had minimal impact on sales.

On a GAAP basis, diluted earnings per share (EPS) for the third quarter of 2024 was $2.71, compared to $2.27 for the third quarter of 2023. On a non-GAAP basis, EPS was $2.93, compared to $2.84 for the third quarter of 2023. This includes a headwind of approximately 2% due to unfavorable foreign exchange.

“We delivered exceptional third quarter results, fueled by new product adoption and improved customer spending trends,” said Dr. Udit Batra, President & CEO, Waters Corporation. “Instruments returned to growth sooner than expected, as liquid chromatography sales to pharma and industrial customers turned positive.”

Dr. Batra continued, “Looking ahead, our strong commercial execution, competitive product portfolio, and excellent operational performance give us confidence in the long-term outlook for Waters.”

Other Highlights

During the third quarter of 2024, sales into the pharmaceutical market increased 2% as reported and 3% in constant currency. Sales into the industrial market increased 9% as reported and 7% in constant currency. Sales into the academic and government market increased 2% as reported and were flat in constant currency.

During the quarter, instrument system sales increased 1% as reported and in constant currency. Recurring revenues, which represent the combination of service and precision chemistries, increased 6% as reported and 7% in constant currency.

Geographically, sales in Asia during the quarter increased 5% as reported and 6% in constant currency. Sales in the Americas increased 1% as reported and in constant currency. Sales in Europe increased 6% as reported and 4% in constant currency.

Unless otherwise noted, sales growth and decline percentages are presented on an as-reported basis. A description and reconciliation of GAAP to non-GAAP results appear in the tables below and can be found on the Company’s website www.waters.com in the Investor Relations section.

Full-Year and Fourth Quarter 2024 Financial Guidance

Full-Year 2024 Financial Guidance

The Company is raising its full-year 2024 sales guidance, and now expects organic constant currency sales growth to be in the range of -0.9% to -0.3%. Currency translation is expected to decrease full-year sales growth by 1.2%. M&A contribution from the Wyatt transaction covering the first four-and-a-half months of the year has added 1.3% to full-year reported sales. The resulting full-year 2024 reported sales growth is expected in the range of -0.8% to -0.2%.

The Company is also raising its full-year 2024 non-GAAP EPS guidance to now be in the range of $11.67 to $11.87, which includes an estimated headwind of approximately 3% due to unfavorable foreign exchange.

Please refer to the tables below for a reconciliation of the projected GAAP to non-GAAP financial outlook for the full year.

Fourth Quarter 2024 Financial Guidance

The Company expects fourth quarter 2024 constant currency sales growth to be in the range of +5.0% to +7.0%. Currency translation is expected to decrease fourth quarter sales growth by 1.7%. The resulting fourth quarter 2024 reported sales growth is expected in the range of +3.3% to +5.3%.

The Company expects fourth quarter 2024 non-GAAP EPS to be in the range of $3.90 to $4.10, which includes an estimated headwind of approximately 3% due to unfavorable foreign exchange.

Please refer to the tables below for a reconciliation of the projected GAAP to non-GAAP financial outlook for the fourth quarter.

Conference Call Details

Waters Corporation will webcast its third quarter 2024 financial results conference call today, November 1, 2024, at 8:00 a.m. Eastern Time. To listen to the call and see the accompanying slide presentation, please visit www.waters.com, select “Investor Relations” under the “About Waters” section, navigate to “Events & Presentations,” and click on the “Webcast.” A replay will be available through November 29, 2024, on the same website by webcast and also by phone at (888) 282-0031.

About Waters Corporation

Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,500 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries. For more information, visit www.waters.com.

Non-GAAP Financial Measures

This press release contains financial measures, such as organic constant currency growth rates, adjusted operating income, adjusted net income, adjusted earnings per diluted share and free cash flow, among others, which are considered “non-GAAP” financial measures under applicable U.S. Securities and Exchange Commission rules and regulations. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, financial information prepared in accordance with U.S. generally accepted accounting principles (GAAP). The Company’s definitions of these non-GAAP measures may differ from similarly titled measures used by others. The non-GAAP financial measures used in this press release adjust for specified items that can be highly variable or difficult to predict. The Company generally uses these non-GAAP financial measures to facilitate management’s financial and operational decision-making, including evaluation of the Company’s historical operating results, comparison to competitors’ operating results and determination of management incentive compensation. These non-GAAP financial measures reflect an additional way of viewing aspects of the Company’s operations that, when viewed with GAAP results and the reconciliations to corresponding GAAP financial measures, may provide a more complete understanding of factors and trends affecting the Company’s business. Because non-GAAP financial measures exclude the effect of items that will increase or decrease the Company’s reported results of operations, management strongly encourages investors to review the Company’s consolidated financial statements and publicly filed reports in their entirety. Reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the tables accompanying this release.

Cautionary Statement

This release contains “forward-looking” statements regarding future results and events. For this purpose, any statements that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words “feels”, “believes”, “anticipates”, “plans”, “expects”, “intends”, “suggests”, “appears”, “estimates”, “projects” and similar expressions, whether in the negative or affirmative, are intended to identify forward-looking statements. The Company’s actual future results may differ significantly from the results discussed in the forward- looking statements within this release for a variety of reasons, including and without limitation, risks related to, and expectations or ability to realize commercial success of the Wyatt transaction; the impact of this transaction on the Company’s business, anticipated progress on Waters’ research programs, development of new analytical instruments and associated software or consumables, manufacturing development and capabilities; the increased indebtedness of the Company as a result of the Wyatt transaction, the repayment of which could impact the Company’s future results, market prospects for its products and sales and earnings guidance; foreign currency exchange rate fluctuations potentially affecting translation of the Company’s future non-U.S. operating results, particularly when a foreign currency weakens against the U.S. dollar; current global economic, sovereign and political conditions and uncertainties, including the effect of new or proposed tariff or trade regulations as well as other new or changed domestic and foreign laws, regulations and policies; changes in inflation and interest rates; the impacts and costs of war, in particular as a result of the ongoing conflicts between Russia and Ukraine and in the Middle East, and the possibility of further escalation resulting in new geopolitical and regulatory instability; the Chinese government’s ongoing tightening of restrictions on procurement by government-funded customers; the Company’s ability to access capital, maintain liquidity and service the Company’s debt in volatile market conditions; risks related to the effects of any pandemic on our business, financial condition, results of operations and prospects; changes in timing and demand for the Company’s products among the Company’s customers and various market sectors, particularly as a result of fluctuations in their expenditures or ability to obtain funding; the ability to realize the expected benefits related to the Company’s various cost-saving initiatives, including workforce reductions and organizational restructurings; the introduction of competing products by other companies and loss of market share, as well as pressures on prices from competitors and/or customers; changes in the competitive landscape as a result of changes in ownership, mergers and continued consolidation among the Company’s competitors; regulatory, economic and competitive obstacles to new product introductions; lack of acceptance of new products and inability to grow organically through innovation; rapidly changing technology and product obsolescence; risks associated with previous or future acquisitions, strategic investments, joint ventures and divestitures, including risks associated with achieving the anticipated financial results and operational synergies; contingent purchase price payments and expansion of our business into new or developing markets; risks associated with unexpected disruptions in operations; failure to adequately protect the Company’s intellectual property, infringement of intellectual property rights of third parties and inability to obtain licenses on commercially reasonable terms; the Company’s ability to acquire adequate sources of supply and its reliance on outside contractors for certain components and modules, as well as disruptions to its supply chain; risks associated with third-party sales intermediaries and resellers; the impact and costs of changes in statutory or contractual tax rates in jurisdictions in which the Company operates as well as shifts in taxable income among jurisdictions with different effective tax rates, the outcome of ongoing and future tax examinations and changes in legislation affecting the Company’s effective tax rate; the Company’s ability to attract and retain qualified employees and management personnel; risks associated with cybersecurity and technology, including attempts by third parties to defeat the security measures of the Company and its third-party partners; increased regulatory burdens as the Company’s business evolves, especially with respect to the U.S. Food and Drug Administration and U.S. Environmental Protection Agency, among others, and in connection with government contracts; regulatory, environmental and logistical obstacles affecting the distribution of the Company’s products, completion of purchase order documentation and the ability of customers to obtain letters of credit or other financing alternatives; risks associated with litigation and other legal and regulatory proceedings; and the impact and costs incurred from changes in accounting principles and practices. Such factors and others are discussed more fully in the sections entitled “Forward-Looking Statements” and “Risk Factors” of the Company’s annual report on Form 10-K for the year ended December 31, 2023, as well as in the sections entitled “Special Note Regarding Forward-Looking Statements” and “Risk Factors” of the Company’s quarterly reports on Form 10-Q for the quarterly periods ended March 30, 2024 and June 29, 2024, as filed with the Securities and Exchange Commission (“SEC”), which discussions are incorporated by reference in this release, as updated by the Company’s future filings with the SEC. The forward-looking statements included in this release represent the Company’s estimates or views as of the date of this release and should not be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this release. Except as required by law, the Company does not assume any obligation to update any forward-looking statements.

Waters Corporation and Subsidiaries

Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

Three Months Ended

Nine Months Ended

September 28,
2024

September 30,
2023

September 28,
2024

September 30,
2023

Net sales

$               740,305

$               711,692

$            2,085,673

$            2,136,942

Costs and operating expenses:

Cost of sales

301,655

291,407

851,685

876,863

Selling and administrative expenses 

169,097

186,748

516,880

555,657

Research and development expenses 

45,336

41,995

136,113

130,559

Purchased intangibles amortization 

11,759

12,116

35,337

20,410

Litigation provision

1,326

11,568

Operating income 

211,132

179,426

534,090

553,453

Other (expense) income, net

(338)

328

1,619

1,364

Interest expense, net

(17,177)

(26,559)

(57,824)

(56,174)

Income from operations before income taxes

193,617

153,195

477,885

498,643

Provision for income taxes

32,114

18,643

71,449

72,614

Net income

$               161,503

$               134,552

$               406,436

$               426,029

Net income per basic common share

$                     2.72

$                     2.28

$                     6.85

$                     7.21

Weighted-average number of basic common shares

59,367

59,093

59,314

59,061

Net income per diluted common share

$                     2.71

$                     2.27

$                     6.83

$                     7.19

Weighted-average number of diluted common shares and equivalents

59,504

59,255

59,471

59,262

 

Waters Corporation and Subsidiaries

Reconciliation of GAAP to Adjusted Non-GAAP

Net Sales by Operating Segments, Products & Services, Geography and Markets

Three Months Ended September 28, 2024 and September 30, 2023

(In thousands)

Constant

Three Months Ended

Percent

Impact of

Currency

September 28, 2024

September 30, 2023

Change

Currency

Growth Rate (a)

NET SALES – OPERATING SEGMENTS

Waters

$

655,652

$

629,348

4 %

0 %

4 %

TA

84,653

82,344

3 %

1 %

2 %

Total

$

740,305

$

711,692

4 %

0 %

4 %

NET SALES – PRODUCTS & SERVICES

Instruments

$

323,076

$

319,431

1 %

0 %

1 %

Service

278,294

263,611

6 %

0 %

6 %

Chemistry

138,935

128,650

8 %

0 %

8 %

Total Recurring

417,229

392,261

6 %

(1 %)

7 %

Total

$

740,305

$

711,692

4 %

0 %

4 %

NET SALES – GEOGRAPHY

Asia

$

251,329

$

238,228

5 %

(1 %)

6 %

Americas

279,136

275,479

1 %

0 %

1 %

Europe

209,840

197,985

6 %

2 %

4 %

Total

$

740,305

$

711,692

4 %

0 %

4 %

NET SALES – MARKETS

Pharmaceutical

$

430,138

$

421,535

2 %

(1 %)

3 %

Industrial

227,740

209,449

9 %

2 %

7 %

Academic & Government

82,427

80,708

2 %

2 %

0 %

Total

$

740,305

$

711,692

4 %

0 %

4 %

(a)

The Company believes that referring to comparable constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation’s net sales. Constant currency growth, a non-GAAP financial measure, measures the change in net sales between current and prior year periods, excluding the impact of foreign currency exchange rates during the current period. See description of non-GAAP financial measures contained in this release.

 

Waters Corporation and Subsidiaries

Reconciliation of GAAP to Adjusted Non-GAAP

Net Sales by Operating Segments, Products & Services, Geography and Markets

Nine Months Ended September 28, 2024 and September 30, 2023

(In thousands)

Organic 

Constant

Nine Months Ended

Percent

Impact of

Impact of

Currency

September 28, 2024

September 30, 2023

Change

Currency

Acquisitions

Growth Rate (a)

NET SALES – OPERATING SEGMENTS

Waters

$

1,840,112

$

1,884,658

(2 %)

(1 %)

2 %

(3 %)

TA

245,561

252,284

(3 %)

(1 %)

0 %

(2 %)

Total

$

2,085,673

$

2,136,942

(2 %)

(1 %)

2 %

(3 %)

NET SALES – PRODUCTS & SERVICES

Instruments

$

859,079

$

964,380

(11 %)

0 %

3 %

(14 %)

Service

812,367

774,478

5 %

(1 %)

1 %

5 %

Chemistry

414,227

398,084

4 %

(1 %)

0 %

5 %

Total Recurring

1,226,594

1,172,562

5 %

(1 %)

1 %

5 %

Total

$

2,085,673

$

2,136,942

(2 %)

(1 %)

2 %

(3 %)

NET SALES – GEOGRAPHY

Asia

$

696,319

$

745,932

(7 %)

(3 %)

1 %

(5 %)

Americas

794,775

804,827

(1 %)

0 %

3 %

(4 %)

Europe

594,579

586,183

1 %

2 %

2 %

(3 %)

Total

$

2,085,673

$

2,136,942

(2 %)

(1 %)

2 %

(3 %)

NET SALES – MARKETS

Pharmaceutical

$

1,220,092

$

1,233,177

(1 %)

(1 %)

2 %

(2 %)

Industrial

644,459

648,754

(1 %)

0 %

1 %

(2 %)

Academic & Government

221,122

255,011

(13 %)

1 %

2 %

(16 %)

Total

$

2,085,673

$

2,136,942

(2 %)

(1 %)

2 %

(3 %)

(a)

The Company believes that referring to comparable organic constant currency growth rates is a useful way to evaluate the underlying performance of Waters Corporation’s net sales. Organic constant currency growth, a non-GAAP financial measure, measures the change in net sales between current and prior year periods, excluding the impact of foreign currency exchange rates during the current period and excluding the impact of acquisitions made within twelve months of the acquisition close date. See description of non-GAAP financial measures contained in this release.

 

Waters Corporation and Subsidiaries

Reconciliation of GAAP to Adjusted Non-GAAP Financials

Three and Nine Months Ended September 28, 2024 and September 30, 2023

(In thousands, except per share data)

Income from

Operations

Selling &

Research &

Operating

Other

before

Provision for

Diluted

Administrative

Development

Operating

Income

(Expense)

Income

Income

Net

Earnings

Expenses(a)

Expenses

Income

Percentage

Income

Taxes

Taxes

Income

per Share

Three Months Ended September 28, 2024

GAAP

$

182,182

$

45,336

$

211,132

28.5 %

$

(338)

$

193,617

$

32,114

$

161,503

$

2.71

Adjustments:

Purchased intangibles amortization (b)

(11,759)

11,759

1.6 %

11,759

2,814

8,945

0.15

Litigation provision (c)

(1,326)

1,326

0.2 %

1,326

318

1,008

0.02

Restructuring costs and certain other items (d)

(1,194)

1,194

0.2 %

1,194

282

912

0.02

Retention bonus obligation (f)

(1,909)

(636)

2,545

0.3 %

2,545

611

1,934

0.03

Adjusted Non-GAAP

$

165,994

$

44,700

$

227,956

30.8 %

$

(338)

$

210,441

$

36,139

$

174,302

$

2.93

Three Months Ended September 30, 2023

GAAP

$

198,864

$

41,995

$

179,426

25.2 %

$

328

$

153,195

$

18,643

$

134,552

$

2.27

Adjustments:

Purchased intangibles amortization (b)

(12,116)

12,116

1.7 %

12,116

2,901

9,215

0.16

Restructuring costs and certain other items (d)

(24,057)

24,057

3.4 %

(651)

23,406

5,387

18,019

0.30

Acquisition related costs (e)

(1,263)

1,263

0.2 %

1,263

303

960

0.02

Retention bonus obligation (f)

(5,725)

(1,909)

7,634

1.1 %

7,634

1,832

5,802

0.10

Adjusted Non-GAAP

$

155,703

$

40,086

$

224,496

31.5 %

$

(323)

$

197,614

$

29,066

$

168,548

$

2.84

Nine Months Ended September 28, 2024

GAAP

$

563,785

$

136,113

$

534,090

25.6 %

$

1,619

$

477,885

$

71,449

$

406,436

$

6.83

Adjustments:

Purchased intangibles amortization (b)

(35,337)

35,337

1.7 %

35,337

8,456

26,881

0.45

Litigation provision and settlement (c)

(11,568)

11,568

0.6 %

11,568

2,776

8,792

0.15

Restructuring costs and certain other items (d)

(10,680)

10,680

0.5 %

10,680

2,617

8,063

0.14

Retention bonus obligation (f)

(11,451)

(3,817)

15,268

0.7 %

15,268

3,664

11,604

0.20

Adjusted Non-GAAP

$

494,749

$

132,296

$

606,943

29.1 %

$

1,619

$

550,738

$

88,962

$

461,776

$

7.76

Nine Months Ended September 30, 2023

GAAP

$

576,067

$

130,559

$

553,453

25.9 %

$

1,364

$

498,643

$

72,614

$

426,029

$

7.19

Adjustments:

Purchased intangibles amortization (b)

(20,410)

20,410

1.0 %

20,410

4,852

15,558

0.26

Restructuring costs and certain other items (d)

(28,881)

28,881

1.4 %

(651)

28,230

6,860

21,370

0.36

Acquisition related costs (e)

(13,298)

13,298

0.6 %

13,298

3,191

10,107

0.17

Retention bonus obligation (f)

(8,368)

(2,790)

11,158

0.5 %

11,158

2,678

8,480

0.14

Adjusted Non-GAAP

$

505,110

$

127,769

$

627,200

29.4 %

$

713

$

571,739

$

90,195

$

481,544

$

8.13

________________________________

(a)

Selling & administrative expenses include purchased intangibles amortization and litigation provisions and settlements.

(b)

The purchased intangibles amortization, a non-cash expense, was excluded to be consistent with how management evaluates the performance of its core business against historical operating results and the operating results of competitors over periods of time.

(c)

Litigation provisions and settlement gains were excluded as these items are isolated, unpredictable and not expected to recur regularly.

(d)

Restructuring costs and certain other items were excluded as the Company believes that the cost to consolidate operations, reduce overhead, and certain other income or expense items are not normal and do not represent future ongoing business expenses of a specific function or geographic location of the Company.

(e)

Acquisition related costs include all incremental expenses incurred, such as advisory, legal, accounting, tax, valuation, and other professional fees. The Company believes that these costs are not normal and do not represent future ongoing business expenses.

(f)

In connection with the Wyatt acquisition, the Company started to recognize a two-year retention bonus obligation that is contingent upon the employee’s providing future service and continued employment with Waters. The Company believes that these costs are not normal and do not represent future ongoing business expenses.

 

Waters Corporation and Subsidiaries

Preliminary Condensed Unclassified Consolidated Balance Sheets

(In thousands and unaudited)

September 28, 2024

December 31, 2023

Cash, cash equivalents and investments

$                331,458

$                395,974

Accounts receivable

669,534

702,168

Inventories

518,994

516,236

Property, plant and equipment, net

642,627

639,073

Intangible assets, net

591,883

629,187

Goodwill

1,306,593

1,305,446

Other assets

450,531

438,770

   Total assets

$             4,511,620

$             4,626,854

Notes payable and debt

$             1,826,248

$             2,355,513

Other liabilities

1,082,273

1,121,000

   Total liabilities

2,908,521

3,476,513

Total stockholders’ equity

1,603,099

1,150,341

   Total liabilities and stockholders’ equity

$             4,511,620

$             4,626,854

 

Waters Corporation and Subsidiaries

Preliminary Condensed Consolidated Statements of Cash Flows

Three and Nine Months Ended September 28, 2024 and September 30, 2023

(In thousands and unaudited)

Three Months Ended

Nine Months Ended

September 28, 2024

September 30, 2023

September 28, 2024

September 30, 2023

Cash flows from operating activities:

Net income

$                     161,503

$                   134,552

$                   406,436

$                   426,029

Adjustments to reconcile net income to net

cash provided by operating activities:

Stock-based compensation

10,647

8,490

32,993

32,224

Depreciation and amortization

47,507

47,807

143,250

117,845

Change in operating assets and liabilities and other, net

(15,077)

(33,031)

(60,695)

(203,411)

Net cash provided by operating activities

204,580

157,818

521,984

372,687

Cash flows from investing activities:

Additions to property, plant, equipment

and software capitalization

(25,618)

(38,047)

(90,377)

(119,044)

Business acquisitions, net of cash acquired

(1,285,907)

(Investments in) proceeds from unaffiliated companies

(425)

651

(1,489)

651

Net change in investments

(8)

(5)

(44)

(21)

Net cash used in investing activities

(26,051)

(37,401)

(91,910)

(1,404,321)

Cash flows from financing activities:

Net change in debt

(180,000)

(125,181)

(530,000)

929,601

Proceeds from stock plans

3,237

9,464

25,073

18,092

Purchases of treasury shares

(141)

(692)

(13,475)

(70,433)

Other cash flow from financing activities, net

20

2,884

15,305

8,178

Net cash used in financing activities

(176,884)

(113,525)

(503,097)

885,438

Effect of exchange rate changes on cash and cash equivalents

2,442

(171)

8,461

2,081

Increase (decrease) in cash and cash equivalents

4,087

6,721

(64,562)

(144,115)

Cash and cash equivalents at beginning of period

326,427

329,693

395,076

480,529

Cash and cash equivalents at end of period

$                     330,514

$                   336,414

$                   330,514

$                   336,414

Reconciliation of GAAP Cash Flows from Operating Activities to Free Cash Flow (a)

Net cash provided by operating activities – GAAP

$                     204,580

$                   157,818

$                   521,984

$                   372,687

Adjustments:

Additions to property, plant, equipment

and software capitalization

(25,618)

(38,047)

(90,377)

(119,044)

Tax reform payments

95,645

72,101

Litigation settlements (received) paid, net

(375)

9,250

(1,125)

Major facility renovations

3,291

12,151

Payment of acquired Wyatt liabilities (b)

25,617

Payment of Wyatt retention bonus obligation (c)

19,770

Free Cash Flow – Adjusted Non-GAAP

$                     178,962

$                   122,687

$                   556,272

$                   362,387

(a)

The Company defines free cash flow as net cash flow from operations accounted for under GAAP less capital expenditures and software capitalizations plus or minus any unusual and non recurring items. Free cash flow is not a GAAP measurement and may not be comparable to free cash flow reported by other companies.

(b)

In connection with the Wyatt acquisition, the Company assumed certain obligations of Wyatt and paid those obligations immediately upon closing the transaction. The Company believes that the assumed obligations do not represent future ongoing business expenses.

(c)

During the nine months ended September 28, 2024, the Company made its first retention payment under the Wyatt retention bonus program. The Company believes that these payments are not normal and do not represent future ongoing business expenses.

 

Waters Corporation and Subsidiaries

Reconciliation of Projected GAAP to Adjusted Non-GAAP Financial Outlook

Twelve Months Ended

Three Months Ended

December 31, 2024

December 31, 2024

Range

Range

Projected Sales

Organic constant currency sales growth rate (a)

(0.9 %)

(0.3 %)

5.0 %

7.0 %

Impact of:

Currency translation

(1.2 %)

(1.2 %)

(1.7 %)

(1.7 %)

Acquisitions

1.3 %

1.3 %

Sales growth rate as reported

(0.8 %)

(0.2 %)

3.3 %

5.3 %

Range

Range

Projected Earnings Per Diluted Share

GAAP earnings per diluted share

$    10.55

$    10.75

$      3.72

$      3.92

Adjustments:

Purchased intangibles amortization 

$      0.60

$      0.60

$      0.15

$      0.15

Litigation settlement

$      0.15

$      0.15

$            –

$            –

Restructuring costs and certain other items 

$      0.14

$      0.14

$            –

$            –

Retention bonus obligation

$      0.23

$      0.23

$      0.03

$      0.03

Adjusted non-GAAP earnings per diluted share

$    11.67

$    11.87

$      3.90

$      4.10

(a) Organic constant currency growth rates are a non-GAAP financial measure that measures the change in net sales between current and prior year periods, excluding the impact of foreign currency exchange rates during the current period and excluding the impact of acquisitions made within twelve months of the acquisition close date. These amounts are estimated at the current foreign currency exchange rates and based on the forecasted geographical sales in local currency, as well as an assessment of market conditions as of today, and may differ significantly from actual results.

These forward-looking adjustment estimates do not reflect future gains and charges that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance.

 

Contact:    Caspar Tudor, Head of Investor Relations – (508) 482-2429

View original content:https://www.prnewswire.com/news-releases/waters-corporation-nyse-wat-reports-third-quarter-2024-financial-results-302293299.html

SOURCE Waters Corporation

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Blanchard Celebrates 45 Years of Empowering Leadership and Organizational Success

Published

on

By

SAN DIEGO, Nov. 1, 2024 /PRNewswire/ — Blanchard®, a global pioneer in leadership development, consulting, and coaching, proudly announces the celebration of its 45-year anniversary. Ken and Margie Blanchard founded the company in 1979 with three simple goals: to make a positive difference in people’s lives, drive human worth and effectiveness in the workplace, and help each client organization become the provider, employer, and investment of choice.

Since its founding, Blanchard has been at the forefront of transforming leaders and organizations through innovative programs, contextualized learning journeys, and coaching designed to foster personal and professional growth.

Over the past 45 years, Blanchard has equipped thousands of organizations across industries with the tools to lead effectively and create lasting impact. With a strong commitment to helping individuals and teams unlock their full potential, the company’s programs have been trusted by Fortune 500 companies, government institutions, and nonprofit organizations worldwide.

“Reaching 45 years is a significant milestone for Blanchard,” says Scott Blanchard, CEO of Blanchard. “It’s a testament to the dedication of our team, the strength of our partnerships, and our unwavering focus on empowering leaders. We’re incredibly proud of the positive change we’ve helped bring to organizations over the years and look forward to continuing our mission for many more.”

Debbie Ung, President, says, “I’m proud of how our company has continually transformed to meet the needs of learners and we remain committed to providing dynamic new learning options to support our vision of leaders powered for good.”

Margie and Ken Blanchard say, “Growing this company has been a constant challenge to remind us to walk our talk. And to think that 45 years have passed. Unbelievable!”

Blanchard’s signature programs, including SLII®, have empowered leaders to adapt their styles to meet the needs of their teams, driving engagement and results. As leadership development evolves to meet the demands of a fast-changing global landscape, Blanchard remains committed to developing new methodologies and tools to serve the next generation of leaders.

For more information about how Blanchard can help your organization thrive, please visit www.blanchard.com.

About Blanchard
Blanchard is a global leader in leadership development, consulting, and coaching. For more than 40 years, Blanchard has partnered with organizations to maximize individual achievement and organizational performance, bringing measurable progress and true transformation. Blanchard’s SLII® is the global leadership model of choice, powering inspired leaders for more than 10,000 organizations worldwide. Blanchard also offers a suite of award-winning solutions through flexible delivery modalities to meet the specific needs of clients and learners. Discover more at www.blanchard.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/blanchard-celebrates-45-years-of-empowering-leadership-and-organizational-success-302293667.html

SOURCE Blanchard

Continue Reading

Technology

PKF O’Connor Davies Publishes 20th Annual Architectural and Engineering Studies

Published

on

By

Reports provide industry benchmarking data, trends and insights impacting firm profitability and productivity

NEW YORK, Nov. 1, 2024 /PRNewswire-PRWeb/ — PKF O’Connor Davies, one of the nation’s largest accounting, tax and advisory practices, today announced the release of its 20th Annual Architectural and Engineering Studies. Based on 2023 financial and operational data provided by a sample of participating architectural and engineering (A&E) firms, the studies reflect the state of the industry and enable firms to benchmark their performance against others as they seek ongoing profitability and growth.

For the first time, the studies provide a historical perspective, highlighting key milestones and industry trends that have shaped the A&E landscape over the past two decades. They also include firms’ current and future use of artificial intelligence, as well as expert insights on emerging trends. The studies present several key takeaways for the A&E industry, including:

During 2023, profit as a percentage of net fee income reached its highest level in the past five years.Firms’ billing multiple increased slightly as they continued their focus on project management efficiencies.Firms’ breakeven multiple and overhead rate continued their upward trend, driven by increases in indirect labor, employee and fringe benefits, and computer and IT investments.Raises as a percentage of base compensation remain higher than historical averages, despite a year-over-year decrease.

“We are excited to release the 20th anniversary edition of the Architectural and Engineering Studies prepared by our dedicated team of industry specialists. These studies have provided valuable insights to the A&E industry and allowed firms to benchmark their results so they may assess their performance in order to continue to grow and improve profitability,” said David M. Sullivan, Jr., Partner and Leader of the Architecture & Engineering Practice at PKF O’Connor Davies. “The A&E industry is going through a period of unprecedented changes. To fully capitalize on future opportunities, it’s crucial for industry leaders to have a strong understanding of industry trends.”

To access the 20th Annual Architectural and Engineering Studies, visit https://www.pkfod.com/annual-architectural-study/ and https://www.pkfod.com/annual-engineering-study/.

About PKF O’Connor Davies

PKF O’Connor Davies is a top-tier accounting, tax and advisory practice with a long history of serving domestic and international clients. “Know Greater Value” speaks to the confidence and guidance that our clients realize when they work with us. It reinforces our commitment to delivering the highest levels of value, expertise and service in everything we do. Our clients Know Greater Connections, Know Greater Insights and Know Greater Value. “PKF O’Connor Davies” is the brand name under which PKF O’Connor Davies LLP and PKF O’Connor Davies Advisory LLC, independently owned entities, provide professional services in an alternative practice structure in accordance with applicable professional standards. PKF O’Connor Davies LLP is a licensed CPA firm that provides attest services and PKF O’Connor Davies Advisory LLC and its subsidiary entities provide tax and advisory services.

For more information, please visit pkfod.com, and follow us on LinkedIn and X (formerly Twitter).

Media Contact

Michelle Goyke, PKF O’Connor Davies, 914-341-7615, mgoyke@pkfod.comhttps://www.pkfod.com/

View original content:https://www.prweb.com/releases/pkf-oconnor-davies-publishes-20th-annual-architectural-and-engineering-studies-302293785.html

SOURCE PKF O’Connor Davies

Continue Reading

Technology

Ziegler Advises Strata Health Solutions Inc. On Acquisition by VitalHub Corp.

Published

on

By

Ziegler, a specialty investment bank, is pleased to announce its role as exclusive financial advisor to Strata Health Solutions Inc. (“Strata Health”, “Strata” or the “Company”) on its acquisition by VitalHub, a leading software company dedicated to empowering Health and Human Services providers.

CHICAGO, Nov. 1, 2024 /PRNewswire-PRWeb/ — Ziegler, a specialty investment bank, is pleased to announce its role as exclusive financial advisor to Strata Health Solutions Inc. (“Strata Health”, “Strata” or the “Company”) on its acquisition by VitalHub, a leading software company dedicated to empowering Health and Human Services providers.

“Ziegler’s guidance on the presentation of our business, financials, and growth strategy led us to this great outcome. We ultimately could not be happier about the partnership with VitalHub…” said Peter Smith, President and CEO of Strata Health Solutions Inc.

Based in Canada, Strata Health designs, builds, and deploys software that improves access and navigation to care. Strata Health has over 80 health system partners and works with over 500 hospitals to provide over 800 thousand patient transitions annually. The company serves customers in Canada, the UK, the US, and New Zealand with offices internationally.

Strata Health extends VitalHub’s solution set into the electronic referral market, a large and growing market opportunity internationally. Poor transitions of care result in fragmented delivery, unsatisfactory patient outcomes, and billions of dollars of inefficient healthcare system spend annually. Strata Health’s digital suite solves for these problems with solutions like electronic referral, waitlist management, and placement automation.

“Strata Health Solutions offers a comprehensive, technology-driven approach to streamline patient transitions across the healthcare continuum, addressing a critical market need for improved efficiency and patient outcomes. Strata Health’s value proposition lies in its ability to significantly improve patient flow logistics, reduce wait times, minimize unplanned readmissions, and ultimately deliver better patient experiences which are themes we are constantly trying to solve for in today’s healthcare environment. Strata’s partnership with VitalHub will create an incredible opportunity to expand electronic referral solutions internationally” stated Grant Chamberlain, Senior Managing Director in Ziegler’s Healthcare Investment Banking Practice.

“Ziegler’s guidance on the presentation of our business, financials, and growth strategy led us to this great outcome. We ultimately could not be happier about the partnership with VitalHub. We look forward to enhancing our product and market roadmap with the support of the VitalHub platform,” said Peter Smith, President and CEO of Strata Health Solutions Inc.

Ziegler’s Healthcare Investment Banking team is focused on delivering best-in-class advisory and financing solutions for companies and organizations across the healthcare industry. In our core practice areas of healthcare services, information technology, hospitals, and senior living, Ziegler is one of the most active M&A firms offering differentiated sell-side, buy-side, recapitalization/restructuring, equity private placement, and strategic partnering services.

For more information about Ziegler, please visit us at http://www.ziegler.com.

About Ziegler:
Ziegler is a privately held investment bank, capital markets, and proprietary investments firm. Specializing in the healthcare, senior living and education sectors, as well as general municipal and structured finance, enables Ziegler to generate a positive impact on the clients and communities it serves. Headquartered in Chicago with regional and branch offices throughout the United States, Ziegler provides its clients with capital raising, strategic advisory services, equity and fixed income sales & trading and research. To learn more, visit http://www.ziegler.com.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. This client’s experience may not be representative of the experience of other clients, nor is it indicative of future performance or success. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

Media Contact

Christine McCarty, Ziegler, 3125961617, cmccarty@ziegler.com, www.ziegler.com

View original content:https://www.prweb.com/releases/ziegler-advises-strata-health-solutions-inc-on-acquisition-by-vitalhub-corp-302293789.html

SOURCE Ziegler

Continue Reading

Trending